Glucose Tolerance Test Clearance in Type 2 Diabetes Mellitus Patients Following a Plant Based Diet and Anti-Gravity Exercise: A Case Series
American Journal of Internal Medicine
Volume 7, Issue 1, January 2019, Pages: 15-21
Received: Feb. 5, 2019; Accepted: Mar. 8, 2019; Published: Mar. 30, 2019
Views 285      Downloads 159
Authors
Pramod Tripathi, Research Department, Freedom from Diabetes Research Foundation, Pune, India
Mamata Hiremath, Research Department, Freedom from Diabetes Research Foundation, Pune, India
Anay Dudhbhate, Research Department, Freedom from Diabetes Research Foundation, Pune, India
Article Tools
Follow on us
Abstract
The following case series documents six patients consulted in the Freedom From Diabetes Research Foundation (FFDRF) in Pune, India, for the treatment of type 2 diabetes mellitus (DM). This study aims to determine the effectiveness of a specifically modified plant based diet combined with anti-gravity exercises (FFD protocol) towards the cessation of the use of oral hypoglycemic agents (OHAs) and/or external insulin to control blood glucose levels and have the ability to clear the Glucose Tolerance Test (GTT). The patients selected for the study had a minimum of 10 years diabetes. Four of them were only on OHAs and two were on external insulin and OHAs. They had followed the FFD protocol and were included in this study only after fulfilling the following parameters- latest average glycated hemoglobin (HbA1C) levels less than 6.5 and not taking any OHAs or insulin for the last 3 months. Initial and latest demographic data was collected. This included weight, waist circumference, fasting blood glucose levels and HbA1C levels. All 6 patients showed a major improvement in the HbA1C levels, loss in body weight and reduction of waist circumference. In conclusion to this case series, these patients were able to undergo and clear the GTT. This study shows that all these patients have reached an advanced stage of diabetes reversal; besides becoming free from any kind of medications, they are also able to handle a 75 gram glucose load with ease. This would have been otherwise impossible for them. Such results are an important milestone in the history of type 2 diabetes mellitus management and give immense hope to diabetics, their family members, diabetes educators, doctors and the world at large.
Keywords
Type 2 Diabetes Mellitus (DM), Freedom from Diabetes (FFD) Protocol, Oral Hypoglycemic Agents (OHA), Glucose Tolerance Test (GTT), Glycated Haemoglobin (HbA1C)
To cite this article
Pramod Tripathi, Mamata Hiremath, Anay Dudhbhate, Glucose Tolerance Test Clearance in Type 2 Diabetes Mellitus Patients Following a Plant Based Diet and Anti-Gravity Exercise: A Case Series, American Journal of Internal Medicine. Vol. 7, No. 1, 2019, pp. 15-21. doi: 10.11648/j.ajim.20190701.15
Copyright
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
Tripathy J. Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2018; Volume 11:381-387.
[2]
Chen I, Magliano D, Zimmet P. The worldwide epidemiology of type 2 diabetes mellitus: present and future prespectives. Nat Rev Endocrinol 2012; 8:228-36
[3]
Dong L, Sun D, Suk K et al. Is an oral glucose tolerance still valid for diagnosing diabetes mellitus? Diabetes and metabolism journal 2016; 40:118-128
[4]
Herman W, Hoerger T, Brandle M, et al. Diabetes prevention program research group. The cost effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2015; 142:323-32
[5]
Jenkins D, Kendall C, Marchie A, Jenkins A, Augustin L, Ludwig D, Barnard N, Anderson J. Type 2 diabetes and the vegetarian diet, The American Journal of Clinical Nutrition, Volume 78, Issue 3, 1 September 2003, Pages 610S–616S, https://doi.org/10.1093/ajcn/78.3.610S
[6]
Kim L, Kim D, Kim K, Park S, Song K. Is an Oral Glucose Tolerance Test Still Valid for Diagnosing Diabetes Mellitus? Diabetes Metab J. 2015; 40(2):118-28.
[7]
Duke S-AS, Colagiuri S, Colagiuri R. Cochrane Metabolic and endocrine Disorders Group. Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2009; 22
[8]
Barnard N, Cohen J, Jenkins D, Turner-McGrievy G, Gloede L, Green A et al. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. The American Journal of Clinical Nutrition. 2009; 89 (5):1588S-1596S.
[9]
Petersen K, Dufour S, Savage D, Bilz S, Solomon G, Yonemitsu S et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proceedings of the National Academy of Sciences. 2007; 104 (31):12587-12594.
[10]
Trapp C, Barnard N. Usefulness of Vegetarian and Vegan Diets for Treating Type 2 Diabetes. Current Diabetes Reports. 2010; 10 (2):152-158.
[11]
Agrawal S, Millett C, Dhillon P, Subramanian S, Ebrahim S. Type of vegetarian diet, obesity and diabetes in adult Indian population. Nutrition Journal. 2014.
[12]
Barnard N, Cohen J, Jenkins D, Turner-McGrievy G, Gloede L, Jaster B et al. A Low-Fat Vegan Diet Improves Glycemic Control and Cardiovascular Risk Factors in a Randomized Clinical Trial in Individuals With Type 2 Diabetes. Diabetes Care. 2006; 29 (8):1777-1783.
[13]
Barnard N, Cohen J, Jenkins D, Turner-McGrievy G, Gloede L, Green A et al. A low-fat vegan diet and a conventional diabetes diet in the treatment of type 2 diabetes: a randomized, controlled, 74-wk clinical trial. The American Journal of Clinical Nutrition. 2009; 89 (5):1588S-1596S.
[14]
American Diabetes Association. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications. Clinical Diabetes. 2012; 20 (2):53-64.
[15]
Kahleova H, Matoulek M, Malinska H, Oliyarnik O, Kazdova L, Neskudla T et al. Vegetarian diet improves insulin resistance and oxidative stress markers more than conventional diet in subjects with Type 2 diabetes. Diabetic Medicine. 2011; 28 (5):549-559.
[16]
Tonstad S, Butler T, Yan R, Fraser G. Type of Vegetarian Diet, Body Weight, and Prevalence of Type 2 Diabetes. Diabetes Care. 2009; 32 (5):791-796.
[17]
Chiu T, Pan W, Lin M, Lin C. Vegetarian diet, change in dietary patterns, and diabetes risk: a prospective study. Nutrition & Diabetes.2018; 8 (1).
[18]
Yokoyama Y, Barnard N, Levin S, Watanabe M. Vegetarian diets and glycemic control in diabetes: a systematic review and meta-analysis. Cardiovascular Diagnosis and Therapy 2014; 4(5): 373-382.
[19]
Lee Y, Park K. Adherence to a Vegetarian Diet and Diabetes Risk: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients. 2017; 9(6): 603.
[20]
Mc Macken M, Shah S. A plant-based diet for the prevention and treatment of type 2 diabetes. Journal of Geriatric Cardiology. 2017; 14: 342-354.
[21]
Tripathi P, Paranjape M, Tripathi R, Khandagale S, Bhagwat G, Kakrani A. Effectiveness of Specifically Modified Plant Based Dietary Intervention and Anti-gravity Exercise in Type 2 Diabetics: A Follow-up Study. International Journal of Diabetes and Endocrinology. Vol. 3, No. 3, 2018, pp. 50-57. DOI: 10.11648/j.ijde.20180303.13.
[22]
Tripathi P, Bhagwat G, Hiremath M, Dudhbhate A, Paranjpe M, Khandagale S. Effectiveness of a 7 Days Residential Integrated Lifestyle Modification Program on Type 2 Diabetes Mellitus: A Single Arm Observational Study. European Journal of Preventive Medicine. Vol. 7, No. 1, 2019, pp. 17-22. DOI: 10.11648/j.ejpm.20190701.14
[23]
Tripathi P, Paranjape M, Hiremath M. Reversal of Metabolic Syndrome with Freedom From Diabetes (FFD) Protocol. Elixir International Journal: ElixirEndocrinology. Issue No. 122, 2018, pp. 52217-52219.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186